DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine

Zhang, GD; Wang, ZD; Song, PP; Zhan, XQ

Zhan, XQ (通讯作者),Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Thorac Surg Dept, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.;Zhan, XQ (通讯作者),Shandong First Med Univ & Shandong Acad Med Sci, Med Sci & Technol Innovat Ctr, 6699 Qingdao Rd, Jinan 250117, Shandong, Peoples R China.

EPMA JOURNAL, 2022; 13 (4): 649

Abstract

Lung cancer has a very high mortality in females and males. Most (similar to 85%) of lung cancers are non-small cell lung cancers (NSCLC). When lung c......

Full Text Link